|Year : 2019 | Volume
| Issue : 6 | Page : 232-235
Analysis of Ki-67 expression in oral premalignant lesions and normal oral mucosa: An immunohistochemical study
Basheer H Beevi1, Suhas Ramananda Nayak1, Celestina D Peter1, Ajay K Haridas2, Lin Jacob2, Asaf Aboobakker3
1 Department of Oral Pathology, Educare Institute of Dental Sciences, Malappuram, Kerala, India
2 Department of Oral Surgery, Educare Institute of Dental Sciences, Malappuram, Kerala, India
3 Department of Oral Medicine and Radiology, Educare Institute of Dental Sciences, Malappuram, Kerala, India
|Date of Web Publication||28-May-2019|
Dr. Suhas Ramananda Nayak
Department of Oral Pathology, Educare Institute of Dental Sciences, Malappuram 676504, Kerala
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Aim: This study aimed to evaluate the Ki-67 expression in oral premalignant lesions and normal oral mucosa. Materials and Methods: The cases were selected on the basis of the details obtained from the patients. A total of 45 specimens were divided into three groups: Group 1 (normal mucosa), Group 2 (clinically and histologically diagnosed as oral lichen planus), and Group 3 (clinically and histologically diagnosed as leukoplakia). Specimens were prepared and the slides for Ki-67 were observed under light microscope with a magnification of ×400. The tissue samples were thoroughly examined, and the pattern of expression was analyzed semiquantitatively by counting the number of positive cells. Results: The mean positive cell count of normal mucosa was 23.20±2.89, of oral lichen planus was 42.82±2.65, and of leukoplakia was 82.14±3.10. There was a statistically significant difference of expression observed between the groups (P < 0.001). On multiple comparisons using Tukey post hoc test, a statistical difference was found between all the three groups. Conclusion: Ki-67 is an easily applicable marker of cell proliferation whose expression correlates well with the disease progression.
Keywords: Ki-67, leukoplakia, normal mucosa, oral lichen planus
|How to cite this article:|
Beevi BH, Nayak SR, Peter CD, Haridas AK, Jacob L, Aboobakker A. Analysis of Ki-67 expression in oral premalignant lesions and normal oral mucosa: An immunohistochemical study. J Pharm Bioall Sci 2019;11, Suppl S2:232-5
|How to cite this URL:|
Beevi BH, Nayak SR, Peter CD, Haridas AK, Jacob L, Aboobakker A. Analysis of Ki-67 expression in oral premalignant lesions and normal oral mucosa: An immunohistochemical study. J Pharm Bioall Sci [serial online] 2019 [cited 2020 Dec 2];11, Suppl S2:232-5. Available from: https://www.jpbsonline.org/text.asp?2019/11/6/232/258847
| Introduction|| |
One of the major health problems in developing countries is oral cancer and it represents the leading cause of death. Squamous carcinomas represent about 3% of human cancers and more than 90% of malignant tumors at oral location are being diagnosed worldwide each year in more than 350,000 new cases.
The cell is the basic, living, structural, and functional unit of the body. Cell proliferation is a biological process of vital importance to all living organisms and is fundamental to both embryonic and postembryonic existence. The control on this important biological process is thought to be lost in cancer, and many studies have reported that abnormal cell proliferation appears to be a precursor and may be a predictor of tumorigenesis.
Molecular biological markers have been suggested to play an important role in the diagnosis and prognostic evaluation of oral potentially malignant disorders. Markers of proliferation, epithelial differentiation, and genomic markers could potentially be a good prospective for improving the prognostic evaluation of precursors of oral cancer.
The most common immunohistochemical cell proliferation marker is Ki-67 antigen. It is a nuclear protein expressed in the G2 and M phases of actively dividing cells. Its nuclear expression during a defined period of the cell cycle represents an advantage in its use as a biological marker of mitotic activity. Ki-67-positive cells are often correlated with the clinical course of the disease. It provides significant information about the degree of aggressiveness and prognosis of the disease. Hence, this study was conducted to evaluate expression of Ki-67 in oral premalignant lesion and normal oral mucosa.
[TAG:2]Materials and Methods[/TAG:2]
This study was conducted in the Department of Oral Pathology, Educare Institute of Dental Sciences, Kerala, India. Histopathology of paraffin-embedded section of specimens was conducted using hematoxylin and eosin (H&E) stain. Histologically proven oral lichen planus (OLP), leukoplakia, and normal mucosa were selected for the study.
The cases were selected on the basis of the details obtained from the patients. A total of 45 specimens were divided into three groups:
Group 1: normal mucosa;
Group 2: clinically and histologically diagnosed as OLP;
Group 3: clinically and histologically diagnosed as leukoplakia.
Thick sections (4 μm) were cut from 10% formalin-fixed tissue, which were then deparaffinized in two changes of xylene for 15 minutes each. Dexylinization was performed by immersing the slides in two changes of absolute alcohol for 1 minute each. Sections were alcoholized by immersing the slides in 90% and 70% alcohol for 1 minute each and then washed for 10 and 5 minutes each with tap water and distilled water, respectively.
Antigen retrieval was carried out by placing the sections in citrate buffer and then keeping in a microwave oven for 10 minutes. Borosil jar was then cooled for 20 minutes in the sink with water. Sections were then rinsed with distilled water for 5 minutes and were then washed with two changes of tris buffer solution (TBS) for 5 minutes each. To block the endogenous peroxidase enzyme activity, the sections were treated with peroxidase block for 10–15 minutes, and then again washed with three changes of TBS for 5 minutes each. Sections were then treated with power block for 15 minutes to block nonspecific reaction with other antigens. Sections were then drained and covered with primary antibody against Ki-67 with dilution of 1:100 for 1 hour to identify tumor markers by antigen–antibody reactions and again washed with TBS as described earlier. To enhance the reaction between primary and secondary antibodies, sections were then treated with superenhancer for 30 minutes, and again washed with TBS. Enzymes were labeled by treating the sections with supersensitive poly-HRP Secondary Antibody and washed with TBS. Chromogen was then added to the sections for 5 minutes to give color to the antigens and sections were again washed with TBS. Sections were then washed with tap water for 5 minutes and were counterstained with hematoxylin for 1 minute and washed with tap water, dried, cleared in xylene, and mounted with dibutylphthalate polystyrene xylene.
Interpretation of Ki-67
The slides for Ki-67 were observed under light microscope with a magnification of ×400. The tissue samples were thoroughly examined, and the pattern of expression was analyzed semiquantitatively by counting the number of positive cells.
Data analyses were performed using SPSS software, version 21, for Windows. One-way analysis of variance was used. P value was appreciated as statistically significant only when it was under 0.05.
| Results|| |
Comparison of Ki-67 with normal mucosa, OLP, and leukoplakia is shown in [Table 1]. The mean positive cell count of normal mucosa was 23.20±2.89, OLP was 42.82±2.65, and leukoplakia was 82.14±3.10. And there was a statistically significant difference of expression observed between the groups (P < 0.001).
|Table 1: Comparison of Ki-67 with normal mucosa, oral lichen planus, and leukoplakia|
Click here to view
[Table 2] reveals the multiple comparisons of normal mucosa, OLP, and leukoplakia using Tukey post hoc test. There was a statistical difference found between all the three groups.
|Table 2: Multiple comparisons of normal mucosa, oral lichen planus, and leukoplakia using Tukey post hoc test|
Click here to view
| Discussion|| |
Ki-67 is a perichromosomally located, cell-cycle-related antigen. Its expression is strictly restricted to dividing cells. Therefore, it is regarded as one of the most potent proliferation markers in the field of molecular pathology. In normal oral mucosa, Ki-67-positive cells are detected dispersedly within the parabasal layer, that is, the two cell strata above basal layer. However, its expression beyond that within the suprabasal layer indicates epithelial dysplasia.
Cell proliferation, a vital biological process, is an important adjunct to histologically based tumor classification and has potential relevance as an indicator of treatment response and relapse. Many studies have reported that abnormal cell proliferation appears to be a precursor and may be a predictor of tumorigenesis.
The monoclonal antibody Ki-67 was first described in 1983 by Johannes Gerdes et al., who suggested that it might be used as a marker for proliferating cells. Immunostaining with antibodies to Ki-67 antigen is well established as a quick and efficient method for evaluating growth fractions of various tumor types because of its distinctive reaction patterns that exclusively involve the proliferating cells.
The results of this study are similar to those of the study conducted by García-Pola Vallejo et al., which stated that an immunohistochemistry study performed on 10 specimens of OLP, oral leukoplakia, dysplasia, and normal mucosa compared Ki-67 expression and found that all the tissue analyzed showed some grade of proliferation in the basal layer. Results were statistically significant among mean of the positive nuclei per millimeter of length in normal mucosa and oral leukoplakia and between normal mucosa, OLP, and oral leukoplakia with dysplasia. Previous studies have compared lichen planus, but in this study we have tried to compare the expression of Ki-67 in OLP, leukoplakia, and normal mucosa and found that expression was significantly higher in leukoplakia than in OLP, which is a chronic immunologic mucocutaneous disease. The possible malignant transformation of OLP is the subject of an ongoing and controversial discussion in the literature. The main criticism of studies on this subject relates to the lack of sufficient data to support the initial diagnosis of OLP in cases that finally developed into squamous cell carcinoma.
The most important factor indicating whether a lesion is progressing toward malignancy is the presence and intensity of dysplasia. Therefore, it is crucial to find markers of these changes.
Cellular proliferation in OLP is either similar to or greater than that in normal oral mucosa. In Neppelberg’s study, the intensity of Ki-67 staining in the epithelium was positive (+) in 77.3% of OLP samples and was (++) in 18.2% of OLP samples, which was significantly higher than that in normal mucosa (P = 0.022). The results obtained in the aforementioned study were similar to those of our study. Zargaran et al. found that Ki-67 expressions in OLP and epithelial dysplasia were similar and reported significantly higher levels in oral cellular carcinoma. This study showed that, in OLP, the risk of turning into malignancy is similar to the risk in epithelial dysplasia.
| Conclusion|| |
In conclusion, Ki-67 is an easily applicable marker of cell proliferation whose expression correlates well with the disease progression. Therefore, it is a marker of malignant transformation and carcinogenesis in oral premalignant lesions, and in future it may serve as a prognostic tool in the early detection of malignancy.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Patel SM, Patel KA, Patel PR, Gamit B, Hathila RN, Gupta S. Expression of p53 and Ki-67 in oral dysplasia and squamous cell carcinoma: An immunohistochemical study. Int J Med Sci Public Health 2014;3:1201-4.
Pardee AB. G1 events and regulation of cell proliferation. Science 1989;246:603-8.
Bacchi CE, Gown AM. Detection of cell proliferation in tissue sections. Braz J Med Biol Res 1993;26:677-87.
Humayun S, Prasad VR. Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical study. Natl J Maxillofac Surg 2011;2:38-46.
] [Full text]
Suwasini S, Chatterjee K, Purkait SK, Samaddar D, Chatterjee A, Kumar M. Expression of p53 protein and Ki-67 antigen in oral leukoplakia with different histopathological grades of epithelial dysplasia. J Int Soc Prev Community Dent 2018;8:513-22.
Kumar KV, Chaithanya KH, Punde P, Thorat A, Jangam AG, Deepthi S. Comparative evaluation of immunohistochemical expression of Ki-67 in oral lichen planus, oral leukoplakia and normal mucosa cases. J Int Oral Health 2015;7:82-7.
Dwivedi N, Chandra S, Kashyap B, Raj V, Agarwal A. Suprabasal expression of ki-67 as a marker for the severity of oral epithelial dysplasia and oral squamous cell carcinoma. Contemp Clin Dent 2013;4:7-12.
] [Full text]
Ross W, Hall PA. Ki67: From antibody to molecule to understanding? Clin Mol Pathol 1995;48:M113-7.
Brown DC, Gatter KC. Monoclonal antibody ki-67: Its use in histopathology. Histopathology 1990;17:489-503.
García-Pola Vallejo MJ, Anitua Roldán MJ, Fernández Alvarez BE, Garcia Martín JM, López-Muñiz A. Study comparative of ki-67 expression in oral lichen planus and oral leukoplakia. Quantitative analysis. Med Oral 2001;6:364-70.
van der Meij EH, Schepman KP, van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: A prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:164-71.
Dragomir LP, Simionescu C, Mărgăritescu C, Stepan A, Dragomir IM, Popescu MR. P53, p16 and Ki67 immunoexpression in oral squamous carcinomas. Rom J Morphol Embryol 2012;53:89-93.
Neppelberg E. Pathological mechanisms in oral lichen planus: A study of apoptosis-regulatory proteins and risk markers for malignant transformation [PhD Thesis]. Norway: Institute of Oral Sciences, Oral Pathology and Forensic Odontology and Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Bergen; 2007.
Zargaran M, Jamshidi S, Eshghyar N, Moghimbeigi A. Suitability/unsuitability of cell proliferation as an indicator of malignant potential in oral lichen planus: An immunohistochemical study. Asian Pac J Cancer Prev 2013;14:6979-83.
[Table 1], [Table 2]